Initial Results of Reteplase in the Treatment of Acute Lower Extremity Arterial Occlusions
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 11 (3) , 289-294
- https://doi.org/10.1016/s1051-0443(07)61419-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Comparison of Reteplase with Alteplase for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Recommended standards for reports dealing with lower extremity ischemia: Revised versionJournal of Vascular Surgery, 1997
- Major mechanistic differences explain the higher clot lysis potency of reteplase over alteplase: lack of fibrin binding is an advantage for bolus application of fibrin-specific thrombolyticsFibrinolysis and Proteolysis, 1997
- Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)The American Journal of Cardiology, 1997
- Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial InfarctionCirculation, 1996
- More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial InfarctionCirculation, 1995
- BM 06.022: A Novel Recombinant Plasminogen ActivatorCardiovascular Drug Reviews, 1993
- Bolus Application of a Novel Recombinant Plasminogen Activator in Acute Myocardial Infarction Patients: Pharmacokinetics and Effects on the Hemostatic SystemAnnals of the New York Academy of Sciences, 1992
- Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial InfarctionAnnals of Internal Medicine, 1991
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988